Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2

Pretty sad state of affairs.
With the Akili arrangement no loner, I assume that means they are also no longer seeking FDA approval, although I don’t remember seeing this stated anywhere. Can anyone confirm?

honestly, I feel FDA approval was almost a last hope in terms of commercialization of this health tech. I don’t see where income will come from going forward, and sadly this has been the e case for the last 4 years.

does anyone recall how many employees they have currently? Is there any real ongoing development?

thinking about cutting my losses finally as I don’t see this ever going anywhere